THE Australian Therapeutic Goods
Administration is being reported
in India media as confirming that
Ranbaxy medications sold in
Australia are safe.
According to The Economic Times,
a TGA spokesperson said that
“at present, there is no evidence
that any of the products in the
Australian market manufactured
by Ranbaxy are of an unacceptable
quality or that there is a danger to
consumers in Australia.”
Ranbaxy has been fighting a US
criminal case where it has pleaded
guilty and agreed to pay a $500m
penalty over the quality of its
products, with the TGA saying it
had independently tested samples
of Ranbaxy products and found
nothing to suggest unacceptable
quality or a danger.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jul 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jul 13
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.